Virtual Ward to Enable Earlier Hospital Discharge
Official title: Virtual Ward for Early Discharge in Patients Receiving Inpatient Care: A Prospective Feasibility Study on Home Monitoring for the Early Discharge of Eligible Hospitalized Patients in an Outpatient Setting
Run by Erasmus Medical Center · NCT06936891 · Data updated 2026-11-12
This project tests whether eligible hospitalized adults can go home sooner and be safely cared for through a Virtual Ward using remote vital-sign monitoring, home diagnostics, and telemedicine support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 306 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Status | Recruiting |
| Started | April 16, 2025 |
| Main results expected | October 16, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT06936891 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) currently hospitalized who are clinically judged suitable for early discharge, have a safe home environment and internet-connected smartphone or tablet, and can use the Digizorg app or have caregiver support are ideal candidates.
✕Probably not a fit
Patients who are hemodynamically unstable, need continuous in-hospital interventions or high-flow oxygen, have severe cognitive impairment without adequate caregiver support, or lack home internet/smartphone access are unlikely to benefit from the Virtual Ward.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center prospective cohort effort at Erasmus MC enrolls adult inpatients who are clinically stable enough for early discharge into one of six predefined care pathways. Enrolled patients leave the hospital earlier and receive hospital-level monitoring and treatment at home via the Digizorg app, digital vital-sign devices, structured anamnesis questionnaires, and clinician oversight. The primary feasibility goal is to determine whether at least 30% of eligible patients can be successfully and safely transferred to the Virtual Ward within current Dutch healthcare conditions. Outcomes include successful transfer rates, safety events, and the practicality of delivering diagnostics and treatments at home across the sub-cohorts.
Why it matters
Potential benefit: If successful, this approach could let more patients recover at home while preserving hospital capacity and maintaining clinical oversight.
How similar studies have gone: A growing body of international hospital-at-home and Virtual Ward programs has shown safety and reduced inpatient days, but feasibility across diverse acute cohorts in the Dutch system remains less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years old). * Currently hospitalized and eligible for early discharge according to clinical judgment. * Ability to provide written informed consent. * Access to a smartphone or tablet with internet connection. * Patient is capable of using the Digizorg app or has support from a caregiver who can assist. * Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available). * Enrollment in one of the predefined Virtual Ward care pathways Exclusion Criteria: * Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home. * Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge. * Patients unable or unwilling to comply with home monitoring procedures. * Patients with significant cognitive impairment without adequate caregiver support. * Patients with a life expectancy less than 30 days, as assessed by the treating physician. * Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol. * Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
Where it's running
-
Erasmus Medical Center
Rotterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Cox van de Weg, MD, PhD — Erasmus Medical Center
- Study coordinator: Michael C. van Herwerden, MD
- Email: m.vanherwerden@erasmusmc.nl
- Phone: +31107040704
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
Automated ABPI for Peripheral Artery Disease: A Pilot Look at Two Devices
This pilot checks if two automated ankle-brachial pressure index devices can reliably detect PAD across symptom levels and after bypass surgery, using patient and clinician feedback for practicality.
-
Tele-diabetes remote monitoring for kids with type 1 diabetes
This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
AI-powered personalized exercise plan for older adults using a wearable app
A wearable-enabled, AI-driven exercise app is tested to see if it’s feasible and acceptable for adults 65+ and whether it can help increase activity, improve mood, and boost quality of life.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.